scholarly article | Q13442814 |
P50 | author | Stephen M Graham | Q63493477 |
P2093 | author name string | T E Taha | |
R L Broadhead | |||
J D Chiphangwi | |||
D R Hoover | |||
N I Kumwenda | |||
P G Miotti | |||
D Markakis | |||
G N Liomba | |||
L van Der Hoeven | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | maternal health | Q6786626 |
P304 | page(s) | E77 | |
P577 | publication date | 2000-12-01 | |
P1433 | published in | Pediatrics | Q7159238 |
P1476 | title | Morbidity among human immunodeficiency virus-1-infected and -uninfected African children | |
P478 | volume | 106 |
Q37591893 | A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants |
Q34410400 | A retrospective study of Human Immunodeficiency Virus transmission, mortality and loss to follow-up among infants in the first 18 months of life in a prevention of mother-to-child transmission programme in an urban hospital in KwaZulu-Natal, South A |
Q22252385 | AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection |
Q36916297 | Acceptance of HIV testing for children ages 18 months to 13 years identified through voluntary, home-based HIV counseling and testing in western Kenya |
Q43063351 | Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people |
Q35065640 | Assessment of the epidemiology and burden of measles in Southern Mozambique |
Q36279151 | Child mortality levels and trends by HIV status in Blantyre, Malawi: 1989-2009. |
Q26749153 | Clinical outcomes of HIV-exposed, HIV-uninfected children in sub-Saharan Africa |
Q24244620 | Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection |
Q24250276 | Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection |
Q40561063 | Decision analysis to guide choice of interventions to reduce mother-to-child transmission of HIV |
Q40724523 | Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants. |
Q57531078 | Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children |
Q37226114 | Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa |
Q35452458 | Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi |
Q37411773 | Effects of postnatal interventions for the reduction of vertical HIV transmission on infant growth and non-HIV infections: a systematic review |
Q35937990 | Epidemiology of Respiratory Disease in Malawi |
Q36177513 | Fatal Pediatric Cerebral Malaria Is Associated with Intravascular Monocytes and Platelets That Are Increased with HIV Coinfection |
Q35901112 | Growth, developmental, and behavioral outcomes of HIV-affected preschool children in Thailand |
Q35077724 | HIV-1 infection and AIDS. |
Q33308717 | HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization |
Q45273875 | Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth |
Q36055407 | High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody |
Q38457057 | Home-based care for orphaned children infected with HIV/AIDS in Uganda. |
Q37386643 | Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers |
Q37425515 | Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination |
Q33972150 | Immunovirological response to combined antiretroviral therapy and drug resistance patterns in children: 1- and 2-year outcomes in rural Uganda |
Q45016203 | Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India |
Q33624111 | Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency |
Q37286746 | Impact of multi-micronutrient supplementation on growth and morbidity of HIV-infected South African children |
Q30370395 | Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. |
Q46988948 | Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART |
Q33624926 | Incidence of World Health Organization stage 3 and 4 events, tuberculosis and mortality in untreated, HIV-infected children enrolling in care before 1 year of age: an IeDEA (International Epidemiologic Databases To Evaluate AIDS) East Africa regiona |
Q28077904 | Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants |
Q34231039 | Long-term follow-up of children in the HIVNET 012 perinatal HIV prevention trial: five-year growth and survival |
Q34154719 | Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study |
Q39569701 | Meeting international goals in child survival and HIV/AIDS. |
Q35729737 | Modelling the Contributions of Malaria, HIV, Malnutrition and Rainfall to the Decline in Paediatric Invasive Non-typhoidal Salmonella Disease in Malawi |
Q37798996 | Mother-to-child transmission of HIV-1 in sub-Saharan Africa: Past, present and future challenges |
Q45200255 | Mother-to-child transmission of HIV: a global perspective |
Q38868088 | Multiple micronutrient supplementation does not reduce diarrhoea morbidity in Ugandan HIV-infected children: a randomised controlled trial |
Q37087787 | PEPFAR scale-up of pediatric HIV services: innovations, achievements, and challenges |
Q34942527 | Paediatric HIV in 2002--a treatable and preventable infection |
Q26747400 | Pattern of Infectious Morbidity in HIV-Exposed Uninfected Infants and Children |
Q40443605 | Presenting symptoms and signs in children referred for palliative care in Malawi |
Q35101274 | Realities and Challenges of a Five Year Follow Up of Mother and Child Pairs on a PMTCT Program in Zimbabwe |
Q46472414 | Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics |
Q39037971 | Respiratory symptoms in people living with HIV and the effect of antiretroviral therapy: a systematic review and meta-analysis |
Q33987771 | Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa |
Q31020587 | Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009. |
Q34511504 | Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy |
Q54533393 | Should treatment be started among all HIV-infected children and then stopped? |
Q36504397 | Simple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo |
Q38928659 | The impact of HIV infection on childhood pneumonia: comparison between developed and developing regions. |
Q39982387 | To treat or not to treat? No longer a question |
Q37290917 | Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children. |
Q35788052 | Triple nucleoside reverse transcriptase inhibitor therapy in children |
Q30397919 | Uptake of HIV testing and outcomes within a Community-based Therapeutic Care (CTC) programme to treat severe acute malnutrition in Malawi: a descriptive study |
Q57019179 | Viral Sepsis in Children |
Q43049174 | Viral coinfections among African children infected with human immunodeficiency virus type 1. |
Q46420805 | nef gene sequence variation among HIV-1-infected African children |
Search more.